scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1586/14787210.2015.1007044 |
P698 | PubMed publication ID | 25641365 |
P50 | author | Luisa Barzon | Q60011989 |
Sebastian Ulbert | Q66429575 | ||
Giorgio Palù | Q67154939 | ||
Monia Pacenti | Q114452192 | ||
P2860 | cites work | Recent progress in West Nile virus diagnosis and vaccination | Q21284433 |
Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort | Q21560788 | ||
Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease | Q24273313 | ||
Development of one-step quantitative reverse transcription PCR for the rapid detection of flaviviruses | Q24288925 | ||
Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes | Q24289053 | ||
Comparison of Flavivirus Universal Primer Pairs and Development of a Rapid, Highly Sensitive Heminested Reverse Transcription-PCR Assay for Detection of Flaviviruses Targeted to a Conserved Region of the NS5 Gene Sequences | Q24289061 | ||
False-Positive Transcription-Mediated Amplification Assay Detection of West Nile Virus in Blood from a Patient with Viremia Caused by an Usutu Virus Infection | Q24289100 | ||
MEGA6: Molecular Evolutionary Genetics Analysis version 6.0 | Q24498082 | ||
Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases | Q24570064 | ||
Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors | Q24570065 | ||
Virus and antibody dynamics in acute west nile virus infection | Q24570066 | ||
Shell Vial Culture assay for the rapid diagnosis of Japanese encephalitis, West Nile and Dengue-2 viral encephalitis | Q25255383 | ||
West Nile virus: review of the literature | Q26827766 | ||
Experimental infection of rhesus macaques and common marmosets with a European strain of West Nile virus | Q27304916 | ||
NS1 protein secretion during the acute phase of West Nile virus infection | Q27472703 | ||
Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus | Q27472775 | ||
Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus | Q27472834 | ||
Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein | Q27472922 | ||
Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus | Q27473288 | ||
Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections | Q27473433 | ||
First international diagnostic accuracy study for the serological detection of West Nile virus infection | Q27480920 | ||
Immunoassay Targeting Nonstructural Protein 5 To Differentiate West Nile Virus Infection from Dengue and St. Louis Encephalitis Virus Infections and from Flavivirus Vaccination | Q27480960 | ||
Application of Modified Shell Vial Culture Procedure for Arbovirus Detection | Q27481277 | ||
Persistence of West Nile Virus-Specific Antibodies in Viremic Blood Donors | Q27481425 | ||
Differentiation of West Nile and St. Louis Encephalitis Virus Infections by Use of Noninfectious Virus-Like Particles with Reduced Cross-Reactivity | Q27481450 | ||
Clinical characteristics and functional outcome of patients with West Nile neuroinvasive disease in Serbia | Q39364140 | ||
The 2012 West Nile encephalitis epidemic in Dallas, Texas | Q39383324 | ||
Detection of West Nile virus lineage 2 in the urine of acute human infections | Q40209387 | ||
Development and evaluation of NS1 specific monoclonal antibody based antigen capture ELISA and its implications in clinical diagnosis of West Nile virus infection | Q40232592 | ||
Findings of long-term depression up to 8 years post infection from West Nile virus | Q40238557 | ||
Simultaneous detection of West Nile and Japanese encephalitis virus RNA by duplex TaqMan RT-PCR. | Q40240002 | ||
Excretion of West Nile virus in urine during acute infection | Q40242372 | ||
A novel quantitative multiplex real-time RT-PCR for the simultaneous detection and differentiation of West Nile virus lineages 1 and 2, and of Usutu virus | Q40254349 | ||
Follow-up study of Greek patients with West Nile virus neuroinvasive disease | Q40261045 | ||
Circulation of West Nile virus lineage 1 and 2 during an outbreak in Italy. | Q40273025 | ||
Novel West Nile virus lineage 1a full genome sequences from human cases of infection in north-eastern Italy, 2011. | Q40273485 | ||
Current practices and evaluation of screening solid organ donors for West Nile virus | Q40286544 | ||
Second external quality assessment of the molecular diagnostic of West Nile virus: are there improvements towards the detection of WNV? | Q40313114 | ||
Non-neuroinvasive West Nile virus infections during the outbreak in Greece | Q40313708 | ||
Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening | Q40315886 | ||
Detection and molecular analysis of West Nile virus infections in birds of prey in the eastern part of Austria in 2008 and 2009. | Q40335752 | ||
Rapid identification of vector-borne flaviviruses by mass spectrometry | Q40360587 | ||
Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening | Q40391646 | ||
Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay | Q40412314 | ||
West Nile virus isolates from India: evidence for a distinct genetic lineage. | Q40456848 | ||
Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation. | Q40465536 | ||
Nucleic acid testing for west nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. | Q40481213 | ||
Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors | Q40487525 | ||
Generic RT-nested-PCR for detection of flaviviruses using degenerated primers and internal control followed by sequencing for specific identification. | Q40510045 | ||
Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus | Q40625774 | ||
West Nile virus surveillance in mosquitoes, April to October 2013, Vojvodina province, Serbia: implications for the 2014 season | Q42217113 | ||
Flavivirus detection and differentiation by a microsphere array assay. | Q42227584 | ||
Propagation, quantification, detection, and storage of West Nile virus | Q42238139 | ||
Evaluation for West Nile Virus (WNV) RNA in urine of patients within 5 months of WNV infection | Q42978598 | ||
A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles | Q43036625 | ||
A PCR-based protocol for generating West Nile virus replicons | Q43047270 | ||
Metagenomic sequencing for virus identification in a public-health setting | Q44568031 | ||
Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features | Q38211715 | ||
Explosive spread of a neuroinvasive lineage 2 West Nile virus in Central Europe, 2008/2009. | Q38889460 | ||
Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans | Q39193233 | ||
Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus | Q27484980 | ||
A single positively selected West Nile viral mutation confers increased virogenesis in American crows | Q27485706 | ||
Frequency of Missed Cases of Probable Acute West Nile Virus (WNV) Infection when Testing for WNV RNA Alone or WNV Immunoglobulin M Alone | Q27488301 | ||
Evaluation of Chimeric Japanese Encephalitis and Dengue Viruses for Use in Diagnostic Plaque Reduction Neutralization Tests | Q27488878 | ||
Lineage 2 West Nile Virus as Cause of Fatal Neurologic Disease in Horses, South Africa | Q27489367 | ||
Persistent Infection with West Nile Virus Years after Initial Infection | Q27490502 | ||
High Throughput Quantitative Colorimetric Microneutralization Assay for the Confirmation and Differentiation of West Nile Virus and St. Louis Encephalitis Virus | Q27490992 | ||
Flavivirus NS1 Structures Reveal Surfaces for Associations with Membranes and the Immune System | Q27681625 | ||
Structural basis of Flavivirus NS1 assembly and antibody recognition | Q27681981 | ||
Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing | Q28265616 | ||
Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes | Q28742961 | ||
RT-PCR/electrospray ionization mass spectrometry approach in detection and characterization of influenza viruses | Q30397685 | ||
Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification | Q30421085 | ||
Review of diagnostic plaque reduction neutralization tests for flavivirus infection | Q30571998 | ||
Human and entomological surveillance of West Nile fever, dengue and chikungunya in Veneto Region, Italy, 2010-2012 | Q31150115 | ||
T7 phage display of Ep15 peptide for the detection of WNV IgG. | Q33268795 | ||
West Nile virus adheres to human red blood cells in whole blood | Q33288216 | ||
Epidemiology of West Nile infection in Volgograd, Russia, in relation to climate change and mosquito (Diptera: Culicidae) bionomics | Q33386895 | ||
West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes | Q33610392 | ||
Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop | Q33638496 | ||
Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort | Q33940173 | ||
Evaluation of prolonged fatigue post-West Nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines | Q34113896 | ||
Acute West Nile virus neuroinvasive infections: cross-reactivity with dengue virus and tick-borne encephalitis virus | Q34207679 | ||
Epidemiology of West Nile disease in Europe and in the Mediterranean Basin from 2009 to 2013 | Q34270985 | ||
The complete sequence of a West Nile virus lineage 2 strain detected in a Hyalomma marginatum marginatum tick collected from a song thrush (Turdus philomelos) in eastern Romania in 2013 revealed closest genetic relationship to strain Volgograd 2007. | Q34287621 | ||
Development of a double antibody sandwich ELISA for West Nile virus detection using monoclonal antibodies against non-structural protein 1 | Q34323186 | ||
Dynamics of West Nile virus persistence in House Sparrows (Passer domesticus) | Q34443128 | ||
West Nile Fever Characteristics among Viremic Persons Identified through Blood Donor Screening | Q34623850 | ||
Putative new West Nile virus lineage in Uranotaenia unguiculata mosquitoes, Austria, 2013. | Q34641665 | ||
Serum neutralization assay can efficiently replace plaque reduction neutralization test for detection and quantitation of West Nile virus antibodies in human and animal serum samples | Q34701336 | ||
Second international diagnostic accuracy study for the serological detection of West Nile virus infection | Q34702511 | ||
West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety | Q34718025 | ||
West nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease | Q34763947 | ||
Antibody responses in humans infected with newly emerging strains of West Nile Virus in Europe | Q34776746 | ||
A hamster-derived West Nile virus isolate induces persistent renal infection in mice | Q34779072 | ||
Characterization of the mouse neuroinvasiveness of selected European strains of West Nile virus | Q34994770 | ||
Isolation of West Nile virus from urine samples of patients with acute infection | Q35035809 | ||
Keratinocytes are cell targets of West Nile virus in vivo | Q35076652 | ||
Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms | Q35531167 | ||
Applications of next-generation sequencing technologies to diagnostic virology | Q35600172 | ||
High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections | Q35665847 | ||
West Nile Virus-associated flaccid paralysis outcome | Q35793924 | ||
Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe | Q35805636 | ||
West Nile virus population genetics and evolution | Q35826344 | ||
Novel flavivirus or new lineage of West Nile virus, central Europe | Q35873293 | ||
Genetic characterization of West Nile virus lineage 2, Greece, 2010. | Q35876730 | ||
Putative new lineage of west nile virus, Spain. | Q35877396 | ||
Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. | Q35979463 | ||
Detection of persistent west nile virus RNA in experimentally and naturally infected avian hosts | Q36213325 | ||
Chronic infections of West Nile virus detected in California dead birds. | Q36893129 | ||
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses | Q37162404 | ||
PROCLEIX West Nile virus assay based on transcription-mediated amplification | Q37206142 | ||
Genome sequencing of West Nile Virus from human cases in Greece, 2012. | Q37235321 | ||
West Nile virus RNA in tissues from donor associated with transmission to organ transplant recipients | Q37262405 | ||
Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies | Q37271674 | ||
Molecular epidemiology and evolution of West Nile virus in North America | Q37295825 | ||
Large human outbreak of West Nile virus infection in north-eastern Italy in 2012 | Q37376390 | ||
Characteristics of antibody responses in West Nile virus-seropositive blood donors | Q37546791 | ||
Clinical manifestations and outcomes of West Nile virus infection | Q37611824 | ||
Vector competence of Culex neavei and Culex quinquefasciatus (Diptera: Culicidae) from Senegal for lineages 1, 2, Koutango and a putative new lineage of West Nile virus | Q37680743 | ||
PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories | Q38009990 | ||
West Nile virus infections in Greece: an update | Q38040148 | ||
Immune responses to West Nile virus infection in the central nervous system | Q38068093 | ||
West Nile virus infection and immunity | Q38074266 | ||
Next-generation sequencing technologies in diagnostic virology | Q38092456 | ||
West Nile virus and kidney disease | Q38102777 | ||
Evaluation of rapid and simple techniques for the enrichment of viruses prior to metagenomic virus discovery. | Q38137615 | ||
Clinical features of West Nile virus epidemic in Dallas, Texas, 2012. | Q38169445 | ||
P433 | issue | 3 | |
P921 | main subject | West Nile virus | Q158856 |
P304 | page(s) | 327-342 | |
P577 | publication date | 2015-02-02 | |
P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
P1476 | title | Latest developments and challenges in the diagnosis of human West Nile virus infection | |
P478 | volume | 13 |
Q40111495 | Detection and sequencing of West Nile virus RNA from human urine and serum samples during the 2014 seasonal period |
Q60925746 | Find the right sample: A study on the versatility of saliva and urine samples for the diagnosis of emerging viruses |
Q47548707 | First detection of tick-borne encephalitis virus RNA in clinical specimens of acutely ill patients in Hungary |
Q38642875 | Global research trends in West Nile virus from 1943 to 2016: a bibliometric analysis |
Q55084344 | Prediction and prevention of urban arbovirus epidemics: A challenge for the global virology community. |
Q43046666 | Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop |
Q58122913 | Surveillance and Diagnosis of West Nile Virus in the Face of Flavivirus Cross-Reactivity |
Q90016243 | The Effects of a Systemwide Diagnostic Stewardship Change on West Nile Virus Disease Ordering Practices |
Q95277396 | Tumor Necrosis Factor-Alpha Signaling May Contribute to Chronic West Nile Virus Post-infectious Proinflammatory State |
Q38577945 | West Nile virus infection in children |
Q92215826 | West Nile virus vaccines - current situation and future directions |
Q28278045 | Zika virus: from pathogenesis to disease control |
Search more.